Enterprise Value
254.6M
Cash
258.2M
Avg Qtr Burn
-22.96M
Short % of Float
22.12%
Insider Ownership
11.75%
Institutional Own.
78.67%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CFT7455 Details Blood disorder, Hematologic malignancies, Blood cancer, Non-Hodgkin lymphoma, Multiple myeloma | Phase 1/2 Data readout | |
CFT1946 Details Cancer, Solid tumor/s | Phase 1/2 Data readout | |
CFT8919 (EGFR) Details Cancer, Non-small cell lung carcinoma, Solid tumor/s | Phase 1 Initiation | |
CFT8634 (BiDAC) Details Rare diseases, Cancer | Failed Discontinued |